It wasn't so long ago that Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company, seemed to be firing on all cylinders. CagriSema, an investigational weight loss medicine, performed well in ...

Novo Nordisk (NVO) is a healthcare company that discovers, develops, and markets medical products. The company operates in ...

Both stocks have huge opportunities still in front of them. When it comes to investing, sometimes you want to take a big swing. After all, it's not always the number of winners in your portfolio that ...

European shares made cautious gains on Monday, with Gucci -owner Kering leading the pack following a leadership change. The ...

Nvidia (NVDA, Financials) said Tuesday it is partnering with Novo Nordisk to accelerate drug discovery using its generative ...

Recursion Pharmaceuticals ( RXRX 2.13%) is not the most famous artificial intelligence (AI) stock on the market, but the ...

Novo Nordisk’s annual report contains an interesting footnote on its key drug, Ozempic, which last year accounted for $19 ...

Nvidia (NVDA.O) will build its first artificial intelligence cloud platform for industrial applications in Germany, CEO ...

Positive news from the laboratory was the wind beneath the wings of Novo Nordisk (NYSE: NVO) stock on Thursday. The Denmark-based pharmaceutical company, famed for its Ozempic and Wegovy drugs, saw ...

NVDA Price Action: According to data from Benzinga Pro, Thursday’s strategic announcements are being cheered by investors.

The MI350 Series consists of Instinct MI350X and MI355X graphics-processing units and platforms, AMD said. Along with the debut of the new offerings, AMD said it partnered with prominent companies ...

Nvidia teams up with Novo Nordisk and IQVIA to boost AI-powered drug development and streamline complex pharmaceutical ...